150 related articles for article (PubMed ID: 15519902)
1. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.
Il'yasova D; Morrow JD; Ivanova A; Wagenknecht LE
Ann Epidemiol; 2004 Nov; 14(10):793-7. PubMed ID: 15519902
[TBL] [Abstract][Full Text] [Related]
2. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
[TBL] [Abstract][Full Text] [Related]
4. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
Mori TA; Croft KD; Puddey IB; Beilin LJ
Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
[TBL] [Abstract][Full Text] [Related]
5. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.
Il'yasova D; Morrow JD; Wagenknecht LE
Obes Res; 2005 Sep; 13(9):1638-44. PubMed ID: 16222068
[TBL] [Abstract][Full Text] [Related]
6. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
[TBL] [Abstract][Full Text] [Related]
8. Key issues in F2-isoprostane analysis.
Nourooz-Zadeh J
Biochem Soc Trans; 2008 Oct; 36(Pt 5):1060-5. PubMed ID: 18793189
[TBL] [Abstract][Full Text] [Related]
9. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571
[TBL] [Abstract][Full Text] [Related]
10. Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry.
Lee CY; Jenner AM; Halliwell B
Biochem Biophys Res Commun; 2004 Jul; 320(3):696-702. PubMed ID: 15240104
[TBL] [Abstract][Full Text] [Related]
11. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
12. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes.
Taylor AW; Bruno RS; Frei B; Traber MG
Anal Biochem; 2006 Mar; 350(1):41-51. PubMed ID: 16448621
[TBL] [Abstract][Full Text] [Related]
13. Biological monitoring of 3-phenoxybenzoic acid in urine by an enzyme-linked immunosorbent assay.
Chuang JC; Van Emon JM; Trejo RM; Durnford J
Talanta; 2011 Feb; 83(5):1317-23. PubMed ID: 21238715
[TBL] [Abstract][Full Text] [Related]
14. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia.
Reuter SD; O'Donovan DJ; Hegemier SE; Smith EO; Heird WC; Fernandes CJ
J Perinatol; 2007 May; 27(5):303-6. PubMed ID: 17363910
[TBL] [Abstract][Full Text] [Related]
15. Interlaboratory comparison of methodologies for the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.
Cooke MS; Barregard L; Mistry V; Potdar N; Rozalski R; Gackowski D; Siomek A; Foksinski M; Svoboda P; Kasai H; Konje JC; Sallsten G; Evans MD; Olinski R
Biomarkers; 2009 Mar; 14(2):103-10. PubMed ID: 19330588
[TBL] [Abstract][Full Text] [Related]
16. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
[TBL] [Abstract][Full Text] [Related]
17. Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
Doncheva N; Penkov A; Velcheva A; Boev M; Popov B; Niagolov Y
Ann Nutr Metab; 2007; 51(1):82-7. PubMed ID: 17356259
[TBL] [Abstract][Full Text] [Related]
18. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays.
Wood L; Ducroq DH; Fraser HL; Gillingwater S; Evans C; Pickett AJ; Rees DW; John R; Turkes A
Ann Clin Biochem; 2008 Jul; 45(Pt 4):380-8. PubMed ID: 18583623
[TBL] [Abstract][Full Text] [Related]
19. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features.
Volpe A; Biasi D; Caramaschi P; Mantovani W; Bambara LM; Canestrini S; Ferrari M; Poli G; Degan M; Carletto A; Pieropan S; Minuz P
Rheumatology (Oxford); 2006 Mar; 45(3):314-20. PubMed ID: 16219641
[TBL] [Abstract][Full Text] [Related]
20. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy.
Walter MF; Blumberg JB; Dolnikowski GG; Handelman GJ
Anal Biochem; 2000 Apr; 280(1):73-9. PubMed ID: 10805523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
